According to the report, the hepatitis B vaccine market is anticipated to grow from USD 6.4 Billion in 2025 to USD 12.7 Billion in 2035 at a CAGR of 7.1% during the forecast. The hepatitis B vaccine market continues to grow, driven by improved immunization coverage programs and the increased utilization of combination vaccines that can simplify childhood vaccination schedules.
Additionally, there is an ongoing collaboration with public health partners in Africa and Southeast Asia, to improve vaccine coverage in rural areas that do not have cold chain supply. Pilot projects are also exploring use of digital applications to enhance tracking and adherence of vaccinations.
Further, ongoing challenges with vaccine hesitancy, logistical capacity, and newly circulating variants of the virus require solution. The market is trending towards thermostable vaccines and single-dose vaccines to improve access and adherence globally across health systems. There is also a continued interest in the development of new adjuvants to improve efficacy and duration of protection in the vaccines. Lastly, public-private partnerships continue to support financing of large coverage voltage programs around the world.
The market for hepatitis B vaccines is supported by global vaccination initiatives and public health programs intended to lessen the prevalence of hepatitis B infection, as well as knowledge of the long duration of the complications of the disease and increasing demand in developing nations.
Several public health challenges affect the market, including vaccine hesitancy, the high costs associated with vaccination programs and unequal availability of health care in developing nations in which hepatitis B tends to have a higher prevalence. Additional challenges come from the reliance on vaccine cold-chain logistics for vaccines to retain stability, and logistical procurement processes.
Further, increased stable, single-dose, and combination vaccines have created numerous growth opportunities, particularly within the context of enhancing vaccination coverage for the public good through public-private partnerships and adult immunization rates.
The go-to-market for hepatitis B vaccines is influenced by world tariff policies limiting vaccine production and distribution costs. For instance, the cost of vaccine production could be affected when tariffs apply to raw materials or components sourced from other countries (e.g., parts sourced from China) and could create a higher cost of manufacturing into the vaccine distribution cost of manufacturing into the vaccine distribution cost. Increases in manufacturing costs are also prospected to increase the price of vaccines, which will negatively affect vaccination efforts, particularly in places with limited resources by affecting affordability.
However, to relieve cost pressure, manufacturers are evaluating multiple approaches to cut expenses; beginning with optimizing production process, as well as working with government authorities to pursue tariff relief for vaccines or their raw materials. In addition, governments and international organizations may have to negotiate trade policies that would meet objectives that promote public health objectives (e.g. market entry for effective hepatitis B vaccines).
Key players in the global hepatitis B vaccine market include prominent companies such as Bharat Biotech, Biological E. Limited, Chengdu Institute of Biological Products Co., Ltd., CSL Limited (Seqirus), Dynavax Technologies Corporation, Emergent BioSolutions Inc., GlaxoSmithKline plc, Hualan Biological, Engineering Inc., Indian Immunologicals Ltd., LG Chem, Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Panacea Biotec, Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd., VBI Vaccines Inc., Walvax Biotechnology Co., Ltd., Zydus Lifesciences Limited, and other key players along with several other key players contributing to market growth through innovation, strategic partnerships, and global expansion.
MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.
800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.
+1(302)303-2617
3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.
Table of Contents
Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography
We will customise the research for you, in case the report listed above does not meet your requirements.
Get 10% Free Customisation